Back
Channel Therapeutics Stock Price Chart
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Sell
37
CHRO
Channel Therapeutics
Last Price:
$1.23
Seasonality Move:
-31.68%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.-
The current trend is moderately bullish and CHRO is experiencing selling pressure, which indicates risk of future bearish movement.
Channel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.21 | Buy |
| 20-day SMA: | 1.08 | Buy |
| 50-day SMA: | 1.2 | Buy |
| 200-day SMA: | 1.14 | Buy |
| 8-day EMA: | 1.22 | Buy |
| 20-day EMA: | 1.15 | Buy |
| 50-day EMA: | 1.21 | Buy |
| 200-day EMA: | 1.38 | Sell |
Channel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 55.45 | Buy |
| Chaikin Money Flow: | -34207 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.95 - 1.19) | Buy |
| Bollinger Bands (100): | (1.09 - 1.95) | Sell |
Channel Therapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Channel Therapeutics Stock
Is Channel Therapeutics Stock a Buy?
-
Channel Therapeutics share price is 1.23 while CHRO 8-day simple moving average is 1.21, which is a Buy signal.
-
The stock price of CHRO is 1.23 while Channel Therapeutics 20-day SMA is 1.08, which makes it a Buy.
-
Channel Therapeutics 50-day simple moving average is 1.20 while CHRO share price is 1.23, making it a Buy technically.
-
CHRO stock price is 1.23 and Channel Therapeutics 200-day simple moving average is 1.14, creating a Buy signal.
CHRO Technical Analysis vs Fundamental Analysis
Sell
37
Channel Therapeutics (CHRO)
is a Sell
Is Channel Therapeutics a Buy or a Sell?
-
Channel Therapeutics stock is rated a SellThe current Channel Therapeutics [CHRO] share price is $1.23. The Score for CHRO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Channel Therapeutics Stock Info
Market Cap:
7.1M
Price in USD:
1.23
Share Volume:
60K
Channel Therapeutics 52-Week Range
52-Week High:
3.80
52-Week Low:
0.45
Sell
37
Channel Therapeutics (CHRO)
is a Sell
Channel Therapeutics Share Price Forecast
-
What is the Channel Therapeutics stock price today?The Channel Therapeutics stock price is 1.23 USD today.
-
Will CHRO stock go up or go down?Channel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Channel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Channel Therapeutics is overvalued.
Is Channel Therapeutics Stock a Buy?
-
Channel Therapeutics share price is 1.23 while CHRO 8-day exponential moving average is 1.22, which is a Buy signal.
-
The stock price of CHRO is 1.23 while Channel Therapeutics 20-day EMA is 1.15, which makes it a Buy.
-
Channel Therapeutics 50-day exponential moving average is 1.21 while CHRO share price is 1.23, making it a Buy technically.
-
CHRO stock price is 1.23 and Channel Therapeutics 200-day simple moving average is 1.38, creating a Sell signal.
Fundamental Analysis of Channel Therapeutics
Is Channel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.05 per share.
Technical Analysis of Channel Therapeutics
Should I short Channel Therapeutics stock?
-
CHRO Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Channel Therapeutics is a Buy
-
Channel Therapeutics Relative Strength Index (RSI) is 55.45, which suggest Channel Therapeutics is overbought
-
The Bollinger Bands (25) for Channel Therapeutics is (0.95 - 1.19), which suggest Channel Therapeutics is a Sell
-
The Bollinger Bands (100) for Channel Therapeutics is (1.09 - 1.95), which suggest Channel Therapeutics is a Sell
* Channel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.